Studies

Uniquity One NSI-8226-201 EE (ALAMERE)

Internal Medicine Immunology Gastroenterology Esophagitis Digestive Disease Adult Subjects

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solrikitug in adult participants with eosinophilic esophagitis.